IRIS
TOCCHETTI, CARLO GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.027
EU - Europa 6.338
NA - Nord America 6.282
SA - Sud America 1.087
AF - Africa 276
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.028
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.030
SG - Singapore 4.348
RU - Federazione Russa 3.012
CN - Cina 1.743
IT - Italia 1.404
HK - Hong Kong 895
BR - Brasile 885
VN - Vietnam 520
DE - Germania 392
FI - Finlandia 299
NL - Olanda 273
CA - Canada 147
GB - Regno Unito 143
UA - Ucraina 138
IN - India 132
FR - Francia 131
SE - Svezia 124
IE - Irlanda 98
CI - Costa d'Avorio 88
AR - Argentina 85
KR - Corea 75
ZA - Sudafrica 71
MX - Messico 67
PL - Polonia 47
AT - Austria 46
BD - Bangladesh 45
ES - Italia 41
EC - Ecuador 39
JP - Giappone 38
LT - Lituania 32
ID - Indonesia 30
IQ - Iraq 29
PT - Portogallo 29
TR - Turchia 27
CO - Colombia 25
BE - Belgio 24
PK - Pakistan 24
BG - Bulgaria 17
MA - Marocco 17
VE - Venezuela 17
EG - Egitto 15
IL - Israele 14
NG - Nigeria 13
SK - Slovacchia (Repubblica Slovacca) 12
PE - Perù 11
AE - Emirati Arabi Uniti 10
KE - Kenya 10
PY - Paraguay 10
AZ - Azerbaigian 9
DZ - Algeria 9
TN - Tunisia 9
UZ - Uzbekistan 9
CZ - Repubblica Ceca 8
ET - Etiopia 8
GE - Georgia 8
IR - Iran 8
PH - Filippine 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
GR - Grecia 7
HR - Croazia 7
TT - Trinidad e Tobago 7
AU - Australia 6
MK - Macedonia 6
NP - Nepal 6
NZ - Nuova Zelanda 6
RO - Romania 6
RS - Serbia 6
TW - Taiwan 6
CL - Cile 5
DK - Danimarca 5
KZ - Kazakistan 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
HT - Haiti 4
JO - Giordania 4
LB - Libano 4
LV - Lettonia 4
PS - Palestinian Territory 4
AO - Angola 3
BJ - Benin 3
GT - Guatemala 3
MD - Moldavia 3
ML - Mali 3
NC - Nuova Caledonia 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
SD - Sudan 3
SN - Senegal 3
TH - Thailandia 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
CM - Camerun 2
CY - Cipro 2
DJ - Gibuti 2
Totale 21.975
Salva come PNG Salva come JPEG
Città #
Singapore 2.055
Hong Kong 891
Chandler 779
Moscow 730
Ashburn 602
Beijing 470
Hefei 415
Santa Clara 276
Naples 261
San Jose 216
Amsterdam 213
Los Angeles 195
Millbury 187
Boston 160
Ho Chi Minh City 159
Nanjing 155
Des Moines 137
Princeton 131
The Dalles 129
Munich 120
Wilmington 109
Redondo Beach 106
Jacksonville 101
Dallas 97
Buffalo 94
São Paulo 92
Dong Ket 86
Lawrence 86
New York 82
Hanoi 77
Seoul 73
Helsinki 70
Napoli 70
Seattle 67
Ottawa 63
Lappeenranta 61
Milan 56
Turku 54
Woodbridge 54
Nuremberg 50
Rome 48
Houston 42
Frankfurt am Main 41
Hebei 40
Orem 40
Chicago 39
Nanchang 39
Warsaw 38
Mexico City 36
Falkenstein 34
Montreal 33
Shenyang 33
Denver 32
London 32
Pune 31
Stockholm 29
Brooklyn 28
Atlanta 27
Council Bluffs 27
Belo Horizonte 26
Guangzhou 24
Kochi 24
Palermo 24
Rio de Janeiro 24
Changsha 23
Haiphong 23
Norwalk 23
Tianjin 22
Toronto 22
Washington 22
Boardman 21
Da Nang 21
Johannesburg 21
Phoenix 21
Caserta 20
Fairfield 20
Tokyo 20
Dearborn 19
Dublin 19
Jiaxing 19
Shanghai 18
Bologna 17
Brasília 17
Poplar 17
Chennai 16
Redwood City 16
Salt Lake City 16
Sofia 16
Vienna 16
Hangzhou 15
Quito 15
San Francisco 15
Turin 15
Augusta 14
Fortaleza 14
Guayaquil 14
Charlotte 13
Chengdu 13
Manchester 13
Biên Hòa 12
Totale 11.258
Salva come PNG Salva come JPEG
Nome #
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice 697
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 164
Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis 154
Meccanismi molecolari della cardiotossicità indotta da antracicline e radioterapia 144
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function 143
Antineoplastic drug-induced cardiotoxicity: A redox perspective 140
Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects 136
Cardiac sympathetic dysfunction in pulmonary arterial hypertension: Lesson from left-sided heart failure 136
Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed 134
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 130
Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients 129
Adapted recreational football Small Sided Games improves cardiac capacity, body composition and muscular fitness in patients with type 2 diabetes: results from a pilot study 129
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes 129
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 129
Myocardial collagen turnover in hypertrophic cardiomyopathy 128
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 126
Dobutamine stress echocardiography in hypertrophic cardiomyopathy 126
Cardiotoxicity of immune checkpoint inhibitors 126
Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy. 125
Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production 125
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 125
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue 123
An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology 122
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart 122
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments 120
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart 120
Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients 119
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled trial 118
The innate immune system in chronic cardiomyopathy: A European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC 118
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 117
Severe Aortic Valve Regurgitation in Relapsing Polychondritis 116
Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities 116
What is the cardiac impact of chemotherapy and subsequent radiotherapy in lymphoma patients 116
The role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a Position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC) 115
Oxidative stress in anticancer therapies-related cardiac dysfunction 115
The Influence of Fiber on Gut Microbiota: Butyrate as Molecular Player Involved in the Beneficial Interplay Between Dietary Fiber and Cardiovascular Health 114
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 113
Mitral peak early diastolic filling velocity to deceleration time ratio as a predictor of prognosis in patients with chronic heart failure and preserved or reduced ejection fraction. 113
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 113
Prevention of cardiovascular complications in elderly cancer patients 113
PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus 112
Permanent atrial fibrillation and pulmonary embolism in elderly patients without deep vein thrombosis: is there a relationship? 112
European Society of Cardiology Core Curriculum for Cardio-Oncology 111
Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. 111
Complex Roads from Genotype to Phenotype in Dilated Cardiomyopathy: Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology 111
Prognostic Significance of Left Atrial Volume Dilatation in Patients with Hypertrophic Cardiomyopathy 110
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 110
Biomarkers in sarcopenia: A multifactorial approach. 110
The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology 110
Common Mechanistic Pathways in Cancer and Heart Failure 110
Editorial: Myocardium regeneration and cardioprotection 108
Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 107
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 107
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 107
Hemodynamic effects of isometric exercise in hypertrophic cardiomyopathy: comparison with normal subjects 106
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment 106
Non-coding RNAs - Update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart 106
Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC) 106
New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management 106
Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease? 105
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors. 105
Aldose Reductase Inhibition or Activation of Transketolase Offset Adverse Metabolic Remodeling Improving Function in Type 2 Diabetes Myocytes Exposed to Hyperglycemia 104
Nitroxyl: A positive inotrope enhancing SR CA(2+) cycling in isolated myocytes 104
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs 104
Novel Therapeutic Approaches and Targets for the Treatment of Cardiovascular and Immunological Diseases 104
Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology 103
Reciprocal organ interactions during heart failure-a position paper from the ESC working group on myocardial function 102
Low-intensity pulsed ultrasound (LIPUS) in heart failure with preserved ejection fraction (HFpEF): lupus in fabula? 102
'Circulating' RNA-based therapies in Cardio-Oncology 101
Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge 101
Physical vs. multidimensional frailty in older adults with and without heart failure 101
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 100
The broad spectrum of cardiotoxicities from immunotherapies 99
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) 99
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis 99
Cardiovascular events and treatment of children with high risk medulloblastoma 99
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology 98
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 97
The continuous heart failure spectrum: moving beyond an ejection fraction classification 97
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study 96
Commentary on “Functional Improvement After Outpatient Cardiac Rehabilitation in Acute Coronary Syndrome Patients is not Related to Improvement in Left Ventricular Ejection Fraction” 96
Time-weighted lactate as a predictor of adverse outcome in acute heart failure 96
Targeting fibrosis in the failing heart with nanoparticles. 96
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC 94
Utility of 2D-speckle tracking echocardiography in diagnosis of left ventricular dysfunction in anti-ErbB2 therapy 94
Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure 94
Innovations in medical therapy of heart failure with reduced ejection fraction 93
Priorities in Cardio-Oncology Basic and Translational Science 93
Myocardial collagen turnover in hypertrophic cardiomyopathy 93
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 93
Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond 93
Circulating miR-10b-5p, miR-193a-3p, and miR-1-3p Are Deregulated in Patients with Heart Failure and Correlate with Hormonal Deficiencies 92
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs 92
Editorial: Novel Therapeutic Strategies for the Treatment of Chronic Diseases 92
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 91
Late INa Inhibition with Ranolazine Blunts Doxorubicin- Induced Cardiac Dysfunction and Remodeling in Mice 90
Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge 90
Functional importance of Insulin-like Growth Factor I receptor COOH-terminal region tyrosine phosphorylation sites. 90
Treatments targeting inotropy 90
Cardiac Remodelling Part 1: From Cells and Tissues to Circulating Biomarkers 90
Totale 11.636
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.343
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021348 0 0 0 0 0 0 52 31 46 60 63 96
2021/20221.132 31 4 15 21 30 32 42 62 101 100 190 504
2022/20232.192 251 122 84 176 273 209 58 258 381 240 105 35
2023/20241.527 47 190 230 115 89 216 72 184 29 48 213 94
2024/20257.219 352 438 40 62 141 443 701 508 609 764 2.481 680
2025/20268.458 1.492 1.079 1.421 1.211 2.267 580 408 0 0 0 0 0
Totale 22.582